Literature DB >> 2779946

Neoplastic characteristics of the DNA found in the plasma of cancer patients.

M Stroun1, P Anker, P Maurice, J Lyautey, C Lederrey, M Beljanski.   

Abstract

About one third of patients with various malignant diseases were found to have extractable amounts of DNA in their plasma whereas no DNA could be detected in normal controls. Using the test established by one of us (M.B.), which is based on decreased strand stability of cancer cell DNA, we have found that several plasma DNA originate from cancer cells.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2779946     DOI： 10.1159/000226740

Source DB:  PubMed          Journal:  Oncology        ISSN： 0030-2414            Impact factor:   2.935


  187 in total

Review 1.  Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer.

Authors:  Vathany Kulasingam; Maria P Pavlou; Eleftherios P Diamandis
Journal:  Nat Rev Cancer       Date:  2010-04-12       Impact factor: 60.716

2.  Circulating tumor DNA: a resuscitative gold mine?

Authors:  Zhaohui Huang; Bing Gu
Journal:  Ann Transl Med       Date:  2015-10

3.  Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth.

Authors:  Alison Tedcastle; Sam Illingworth; Alice Brown; Leonard W Seymour; Kerry D Fisher
Journal:  Mol Ther       Date:  2015-12-28       Impact factor: 11.454

Review 4.  Genomic targets in saliva.

Authors:  Bernhard G Zimmermann; Noh Jin Park; David T Wong
Journal:  Ann N Y Acad Sci       Date:  2007-03       Impact factor: 5.691

5.  Plasma DNA restoration for PCR applications.

Authors:  Y R Arias; E F Carrillo; F A Aristizábal
Journal:  J Clin Pathol       Date:  2007-08       Impact factor: 3.411

6.  Liquid Biopsy in Breast Cancer: Circulating Tumor Cells and Circulating Tumor DNA.

Authors:  Tae-Kyung Yoo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Liquid biopsy and its role in an advanced clinical trial for lung cancer.

Authors:  Donald J Johann; Mathew Steliga; Ik J Shin; Donghoon Yoon; Konstantinos Arnaoutakis; Laura Hutchins; Meeiyueh Liu; Jason Liem; Karl Walker; Andy Pereira; Mary Yang; Susanne K Jeffus; Erich Peterson; Joshua Xu
Journal:  Exp Biol Med (Maywood)       Date:  2018-02

8.  Histone deacetylation, as opposed to promoter methylation, results in epigenetic BIM silencing and resistance to EGFR TKI in NSCLC.

Authors:  Mingchuan Zhao; Yishi Zhang; Jiayu Li; Xuefei Li; Ningning Cheng; Qi Wang; Weijing Cai; Chao Zhao; Yayi He; Jianhua Chang; Caicun Zhou
Journal:  Oncol Lett       Date:  2017-11-14       Impact factor: 2.967

9.  Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched.

Authors:  José Miguel García; Vanesa García; Cristina Peña; Gemma Domínguez; Javier Silva; Raquel Diaz; Pablo Espinosa; Maria Jesús Citores; Manuel Collado; Félix Bonilla
Journal:  RNA       Date:  2008-05-02       Impact factor: 4.942

10.  Mutations of p53 gene can be detected in the plasma of patients with large bowel carcinoma.

Authors:  F Mayall; G Jacobson; R Wilkins; B Chang
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.